Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From

Oct 2, 2019

This week's View takes a look at which patients without known cardiovascular disease are most likely to experience net benefit from aspirin therapy for primary prevention, the outcomes with angioplasty with paclitaxel-coated balloon versus repeat stenting with drug-eluting stent in patients undergoing treatment for in-stent restenosis, and key points to remember from a JACC Review Topic of the Week on the cardiovascular toxicities of immune checkpoint inhibitors.